Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abrams

Showing results (361-370 of 371) with videos related to

Pageof 38
Sort By:
Journal for Immunotherapy of Cancer|September 23, 2022
Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulatorLiliana Oliver, Rydell Alvarez, Raquel Diaz, et al.
Cancer Cell|February 5, 2022
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancerAftab Alam, Eric Levanduski, Parker Denz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2018
Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER ConsortiumChi-Chen Hong, Lara E Sucheston-Campbell, Song Liu, et al.
JCI Insight|February 8, 2019
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironmentKelly L Singel, Tiffany R Emmons, Anm Nazmul H Khan, et al.
JAMA Network Open|October 7, 2025
Developing Medical Cannabis Competencies: A Consensus StatementYuval Zolotov, Leslie Mendoza Temple, Richard Isralowitz, et al.
The Journal of Experimental Medicine|June 27, 2019
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCsJérôme Mastio, Thomas Condamine, George Dominguez, et al.
Cancer Cell|December 12, 2025
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunityYihan Zuo, David J Vohwinkel, Bowen Dong, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
International Journal of Cancer|March 7, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumabChristos Fountzilas, Spencer Rosario, Agnieszka K Witkiewicz, et al.
Cancer Cell|August 8, 2025
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinomaNicholas J Salgia, Adil Khan, Wilhelm M Aubrecht, et al.
Pageof 38

Showing results (361-370 of 371) with videos related to

Sort By:
Pageof 38
Journal for Immunotherapy of Cancer|September 23, 2022
Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulatorLiliana Oliver, Rydell Alvarez, Raquel Diaz, et al.
Cancer Cell|February 5, 2022
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancerAftab Alam, Eric Levanduski, Parker Denz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2018
Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER ConsortiumChi-Chen Hong, Lara E Sucheston-Campbell, Song Liu, et al.
JCI Insight|February 8, 2019
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironmentKelly L Singel, Tiffany R Emmons, Anm Nazmul H Khan, et al.
JAMA Network Open|October 7, 2025
Developing Medical Cannabis Competencies: A Consensus StatementYuval Zolotov, Leslie Mendoza Temple, Richard Isralowitz, et al.
The Journal of Experimental Medicine|June 27, 2019
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCsJérôme Mastio, Thomas Condamine, George Dominguez, et al.
Cancer Cell|December 12, 2025
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunityYihan Zuo, David J Vohwinkel, Bowen Dong, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
International Journal of Cancer|March 7, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumabChristos Fountzilas, Spencer Rosario, Agnieszka K Witkiewicz, et al.
Cancer Cell|August 8, 2025
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinomaNicholas J Salgia, Adil Khan, Wilhelm M Aubrecht, et al.
Pageof 38